FDCNSEFDC Limited· Pharmaceuticals & BiotechnologyHighNegative
Announced Fri, 17 Oct, 2025 · 17:48 IST

FDC names Vishal Shah as CFO after Vijay Bhatt's resignation

Cfo ResignedKmp ResignedManagement Changes View source PDFExplain this filing

FDC · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.3%Reaction day
₹436.45
prior close
₹439.90
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+1.0%-1.3% vs market
Pharmaceuticals peers, median of 153sector+0.3%-0.6% vs sector

On the reaction day the stock moved 1.3 pts less than Nifty Microcap 250 and 0.6 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.5
10m
-0.0
15m
-0.3
30m
-0.8
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.3+1.0-1.3+0.3-0.6
Next day
+2.5+2.0+0.4+0.9+1.5
2d
+0.1+1.6-1.4+0.6-0.5
3d
-1.5+1.2-2.8+0.3-1.8
4d
-1.0+1.6-2.6+0.3-1.3
5d
-1.0+1.9-2.9+0.1-1.1
1w
+4.0+2.1+1.9+0.6+3.4
15d
-6.7+1.0-7.7-1.0-5.7
1m
-5.6+0.2-5.8-1.9-3.7
2m
-5.5-3.1-2.4-4.1-1.4
3m
-12.2-10.9-1.3-11.9-0.4
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 153Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

FDC Limited said Vijay Dharmadatt Bhatt resigned as Chief Financial Officer and key managerial personnel to pursue a better opportunity outside the company. His duties end after market close on October 20, 2025. Vishal Shah, with about 20 years of finance experience in pharmaceuticals, was appointed CFO and key managerial personnel effective October 24, 2025.

Likely market impact

A planned handover limits management disruption, but investors may focus on the finance leadership transition and the new CFO's execution.